-
1
-
-
0032538362
-
-
For a review, see: D. Lucet, T.L. Gall, and C. Mioskowski Angew. Chem., Int. Ed. 37 1998 2580
-
(1998)
Angew. Chem., Int. Ed.
, vol.37
, pp. 2580
-
-
Lucet, D.1
Gall, T.L.2
Mioskowski, C.3
-
5
-
-
0028987923
-
-
For example, see: R.T. Lewis, A.M. Macleod, K.J. Merchant, F. Kelleher, I. Sanderson, R.H. Herbert, M.A. Cascieri, S. Sadowski, R.G. Ball, and K. Hoogsteen J. Med. Chem. 38 1995 923
-
(1995)
J. Med. Chem.
, vol.38
, pp. 923
-
-
Lewis, R.T.1
MacLeod, A.M.2
Merchant, K.J.3
Kelleher, F.4
Sanderson, I.5
Herbert, R.H.6
Cascieri, M.A.7
Sadowski, S.8
Ball, R.G.9
Hoogsteen, K.10
-
6
-
-
0035932606
-
-
For examples, see Refs. 3 and C.J. Dinsmore, J.M. Bergman, M.J. Bogusky, J.C. Culberson, K.A. Hamilton, and S.L. Graham Org. Lett. 3 2001 865
-
(2001)
Org. Lett.
, vol.3
, pp. 865
-
-
Dinsmore, C.J.1
Bergman, J.M.2
Bogusky, M.J.3
Culberson, J.C.4
Hamilton, K.A.5
Graham, S.L.6
-
8
-
-
0028200760
-
-
See Refs. 2a and H. Fukushi, H. Mabuchi, Z. Terashita, K. Nishikawa, and H. Sugihara Chem. Pharm. Bull. 42 1994 551
-
(1994)
Chem. Pharm. Bull.
, vol.42
, pp. 551
-
-
Fukushi, H.1
Mabuchi, H.2
Terashita, Z.3
Nishikawa, K.4
Sugihara, H.5
-
9
-
-
0012417764
-
-
Tosylate or mesylate displacement has also been reported, potentially also going through an aziridine intermediate: X.E. Hu, N.K. Kim, and B. Leoussal Org. Lett. 4 2002 4499
-
(2002)
Org. Lett.
, vol.4
, pp. 4499
-
-
Hu, X.E.1
Kim, N.K.2
Leoussal, B.3
-
10
-
-
0032535314
-
-
F.G. Salituro, C.T. Baker, J.J. Court, D.D. Deininger, E.E. Kim, B. Li, P.M. Novak, B.G. Rao, S. Pazhanisamy, M.D. Porter, W.C. Schairer, and R.D. Tung Bioorg. Med. Chem. Lett. 8 1998 3637
-
(1998)
Bioorg. Med. Chem. Lett.
, vol.8
, pp. 3637
-
-
Salituro, F.G.1
Baker, C.T.2
Court, J.J.3
Deininger, D.D.4
Kim, E.E.5
Li, B.6
Novak, P.M.7
Rao, B.G.8
Pazhanisamy, S.9
Porter, M.D.10
Schairer, W.C.11
Tung, R.D.12
-
11
-
-
0029897442
-
-
H. Sajiki, K.Y. Ong, S.T. Nadler, H.E. Wages, and T.J. McMurry Synth. Commun. 26 1996 2511
-
(1996)
Synth. Commun.
, vol.26
, pp. 2511
-
-
Sajiki, H.1
Ong, K.Y.2
Nadler, S.T.3
Wages, H.E.4
McMurry, T.J.5
-
15
-
-
32244432754
-
-
see Ref. 2b.
-
For example, see Ref. 2b.
-
-
-
-
16
-
-
32244448351
-
-
WO 2004/60872 A1, 22 July 2004.
-
During the preparation of this manuscript, an isolated example of the Red-Al reduction of a chiral Boc-protected amino acid-derived secondary amide was found in the recent patent literature: Liebeschuetz, J. W.; Sheehan, S. M.; Watson, B. M. WO 2004/60872 A1, 22 July 2004.
-
-
-
Liebeschuetz, J.W.1
Sheehan, S.M.2
Watson, B.M.3
-
17
-
-
0035830582
-
-
For examples, see Refs. 2c and S. Manku, C. Laplante, D. Kopac, T. Chan, and D.G. Hall J. Org. Chem. 66 2001 874
-
(2001)
J. Org. Chem.
, vol.66
, pp. 874
-
-
Manku, S.1
Laplante, C.2
Kopac, D.3
Chan, T.4
Hall, D.G.5
-
18
-
-
0033535524
-
-
E.J. Jacobsen, L.S. Stelzer, R.E. TenBrink, K.L. Belonga, D.B. Carter, H.K. Im, W.B. Im, V.H. Sethy, A.H. Tang, P.F. VonVoigtlander, J.D. Petke, W. Zhong, and J.W. Mickelson J. Med. Chem. 42 1999 1123
-
(1999)
J. Med. Chem.
, vol.42
, pp. 1123
-
-
Jacobsen, E.J.1
Stelzer, L.S.2
Tenbrink, R.E.3
Belonga, K.L.4
Carter, D.B.5
Im, H.K.6
Im, W.B.7
Sethy, V.H.8
Tang, A.H.9
Vonvoigtlander, P.F.10
Petke, J.D.11
Zhong, W.12
Mickelson, J.W.13
-
19
-
-
0027759664
-
-
For example, see: X. He, L.P. Raymon, M.V. Mattson, M.E. Eldefrawi, and B.R. de Costa J. Med. Chem. 36 1993 4075
-
(1993)
J. Med. Chem.
, vol.36
, pp. 4075
-
-
He, X.1
Raymon, L.P.2
Mattson, M.V.3
Eldefrawi, M.E.4
De Costa, B.R.5
-
20
-
-
0028829127
-
-
For example, see: P.A. Hipskind, J.J. Howbert, S. Cho, J.S. Cronin, S.L. Fort, F.O. Ginah, G.J. Hansen, B.E. Huff, K.L. Lobb, M.J. Martinelli, A.R. Murray, J.A. Nixon, M.A. Staszak, and J.D. Copp J. Org. Chem. 60 1995 7033
-
(1995)
J. Org. Chem.
, vol.60
, pp. 7033
-
-
Hipskind, P.A.1
Howbert, J.J.2
Cho, S.3
Cronin, J.S.4
Fort, S.L.5
Ginah, F.O.6
Hansen, G.J.7
Huff, B.E.8
Lobb, K.L.9
Martinelli, M.J.10
Murray, A.R.11
Nixon, J.A.12
Staszak, M.A.13
Copp, J.D.14
-
21
-
-
0025845439
-
-
An achiral Boc-glycine derivative has been reduced with Red-Al previously: V.G. Beylin, N.L. Colbry, A.B. Giordani, O.P. Goel, D.R. Johnson, R.L. Leeds, B. Leja, E.P. Lewis, D.M. Lustgarten, H.D.H. Showalter, A.D. Secrcel, M.D. Reily, S.E. Uhlendorf, and K.A. Zisek J. Heterocycl. Chem. 28 1991 517
-
(1991)
J. Heterocycl. Chem.
, vol.28
, pp. 517
-
-
Beylin, V.G.1
Colbry, N.L.2
Giordani, A.B.3
Goel, O.P.4
Johnson, D.R.5
Leeds, R.L.6
Leja, B.7
Lewis, E.P.8
Lustgarten, D.M.9
Showalter, H.D.H.10
Secrcel, A.D.11
Reily, M.D.12
Uhlendorf, S.E.13
Zisek, K.A.14
-
23
-
-
32244440179
-
-
note
-
4, filtered, and concentrated, giving a glassy solid. THF (1.5 mL) and toluene (3.1 mL) were added with stirring, and the mixture was cooled to <5°C. Red-Al (6.90 mL, 23.0 mmol) was added dropwise, keeping the temperature ≤20°C. The clear solution was heated to 40°C. After 14 h, the solution was cooled to <5°C and 5 N NaOH (10 mL) was added carefully, keeping the temperature <25°C. After stirring for 20 min at room temperature, toluene (30 mL) was added, the layers were separated, and the organic layer was washed with 5 N NaOH (2 × 10 mL) and concentrated. Purification by flash column chromatography (10-30% MTBE/hexanes) gave 11g (R = i-Pr, R′ = Ph, 1.11 g, 3.99 mmol, 87% yield).
-
-
-
-
24
-
-
32244445019
-
-
note
-
3): δ 155.9, 139.0, 129.2 × 2, 128.5 × 2, 126.3, 79.2, 63.3, 55.9, 50.6, 50.4, 50.1, 42.7, 38.4, 32.8, 31.0, 28.5 × 3, 27.0, 25.0, 23.1, 22.8, 15.7.
-
-
-
-
25
-
-
32244439721
-
-
note
-
The stereochemical integrity of each reduction was assumed based on the analysis of compound 18 (Scheme 4).
-
-
-
-
27
-
-
32244435378
-
-
note
-
2 at 2% per min with a 3 min hold at 40% MeOH; 1.5 mL/min; 200 bar; 35°C; 215 nm; retention times: (R)-18 = 16.8 min, (S)-18 = 15.5 min.
-
-
-
|